Neurology Research International最新文献

{"title":"Focused Ultrasound (FUS) for Chronic Pain Management: Approved and Potential Applications.","authors":"Lazzaro di Biase, Emma Falato, Maria Letizia Caminiti, Pasquale Maria Pecoraro, Flavia Narducci, Vincenzo Di Lazzaro","doi":"10.1155/2021/8438498","DOIUrl":"10.1155/2021/8438498","url":null,"abstract":"<p><p>Chronic pain is one of the leading causes of disability and disease burden worldwide, accounting for a prevalence between 6.9% and 10% in the general population. Pharmacotherapy alone results ineffective in about 70-60% of patients in terms of a satisfactory degree of pain relief. Focused ultrasound is a promising tool for chronic pain management, being approved for thalamotomy in chronic neuropathic pain and for bone metastases-related pain treatment. FUS is a noninvasive technique for neuromodulation and for tissue ablation that can be applied to several tissues. Transcranial FUS (tFUS) can lead to opposite biological effects, depending on stimulation parameters: from reversible neural activity facilitation or suppression (low-intensity, low-frequency ultrasound, LILFUS) to irreversible tissue ablation (high-intensity focused ultrasounds, HIFU). HIFU is approved for thalamotomy in neuropathic pain at the central nervous system level and for the treatment of facet joint osteoarthritis at the peripheral level. Potential applications include HIFU at the spinal cord level for selected cases of refractory chronic neuropathic pain, knee osteoarthritis, sacroiliac joint disease, intervertebral disc nucleolysis, phantom limb, and ablation of peripheral nerves. FUS at nonablative dosage, LILFUS, has potential reversible and tissue-selective effects. FUS applications at nonablative doses currently are at a research stage. The main potential applications include targeted drug and gene delivery through the Blood-Brain Barrier, assessment of pain thresholds and study of pain, and reversible peripheral nerve conduction block. The aim of the present review is to describe the approved and potential applications of the focused ultrasound technology in the field of chronic pain management.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"8438498"},"PeriodicalIF":1.7,"publicationDate":"2021-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39181843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Ischemic and Hemorrhagic Stroke in the Medical Ward of Dessie Referral Hospital, Northeast Ethiopia: A Retrospective Study.","authors":"Hussen Abdu,&nbsp;Fentaw Tadese,&nbsp;Girma Seyoum","doi":"10.1155/2021/9996958","DOIUrl":"https://doi.org/10.1155/2021/9996958","url":null,"abstract":"<p><strong>Background: </strong>Distinguishing the category of stroke plays a vital role in planning patient care. Simple clinical findings help distinguish the type of stroke. However, there is a need for diagnostic imaging. In Ethiopia, stroke is the most common neurological condition in patients admitted to hospitals. Yet, there are limited data on comparisons of stroke subtypes. Thus, this study was designed to determine the prevalence of stroke and to compare ischemic and hemorrhagic strokes.</p><p><strong>Methods: </strong>A retrospective cross-sectional study design was employed. Medical records containing complete information and confirmed diagnosis using imaging techniques were included. The data were entered into SPSS version 24.0 for analysis. Results with a <i>P</i> value of <0.05 were considered statistically significant.</p><p><strong>Results: </strong>From a total of 312 stroke patients, 204 (65.4%) patients were admitted due to ischemic stroke. More females, 59 (18.9%), were admitted for hemorrhagic stroke than males. In both ischemic, 175 (56.1%) and hemorrhagic, 91 (29.2%) stroke cases, most of the patients were 45 years and above. Middle cerebral artery territory was the most common site of arterial territory infarctions in ischemic stroke, 158 (50.7%). Middle cerebral artery territory also was the most common site of hematoma in hemorrhagic stroke, 91 (29.2%). Infarctions in more than one lobe of the cerebrum (16.4%) and intracerebral hemorrhage in multiple areas of the cerebrum (7.4%) were observed in ischemic as well as hemorrhagic stroke cases. Most of the ischemic, 124 (39.8%), and hemorrhagic, 39 (12.5%), stroke patients presented loss of sensation and weakness of body parts. Hypertension was observed in 124 (39.8%) ischemic and 73 (23.4%) hemorrhagic stroke patients. The mortality rate of ischemic stroke, 47 (15.3%), was two times higher than hemorrhagic stroke, 20 (6.5%). Hypertension was the most common predictor of death in both ischemic and hemorrhagic stroke cases.</p><p><strong>Conclusions: </strong>Ischemic stroke is a common type of stroke in the medical ward of the study hospital. More females were affected by hemorrhagic stroke than males. Middle cerebral artery territory was the most affected area of the brain in both ischemic and hemorrhagic strokes. Most ischemic and hemorrhagic stroke patients were admitted due to loss of sensation and weakness of body parts. Hypertension was the most common risk factor of stroke as well as a predictor of stroke-related deaths. Identification of the stroke subtypes may be important in the management of stroke. Thus, health professionals, government officials, community leaders, and the population at large could be involved in creating awareness about antecedent risk factors and clinical presentations of stroke subtypes.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"9996958"},"PeriodicalIF":1.5,"publicationDate":"2021-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39181844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Retinal Structure and Optic Nerve Function Changes in Multiple Sclerosis: Longitudinal Study with 1-Year Follow-Up.","authors":"Riwanti Estiasari,&nbsp;Adisresti Diwyacitta,&nbsp;Muhammad Sidik,&nbsp;Ni Nengah Rida Ariarini,&nbsp;Freddy Sitorus,&nbsp;Saraf Shafa Marwadhani,&nbsp;Kartika Maharani,&nbsp;Darma Imran,&nbsp;Reza Aditya Arpandy,&nbsp;David Pangeran,&nbsp;Manfaluthy Hakim","doi":"10.1155/2021/5573839","DOIUrl":"https://doi.org/10.1155/2021/5573839","url":null,"abstract":"<p><strong>Background: </strong>Multiple sclerosis (MS) is an autoimmune disease characterized by inflammation and demyelination of the central nervous system which often involves the optic nerve even though only 20% of the patients experience optic neuritis (ON).</p><p><strong>Objective: </strong>This study aims to compare the retinal structure and optic nerve function between patients with MS and healthy controls (HCs), evaluate optic nerve alterations in MS over 1-year follow-up, and analyze its correlations with disease duration, number of relapses, degree of disability, and different subtypes.</p><p><strong>Methods: </strong>This is a prospective cohort study involving 58 eyes of MS patients. Optic nerve function was evaluated with best-corrected visual acuity (BCVA), contrast sensitivity, and P100 latency, while the retinal structure was evaluated from the GCIPL and RNFL thickness measured with optical coherence tomography (OCT) and fundus photography.</p><p><strong>Results: </strong>The MS group had lower BCVA (<i>p</i>=0.001), contrast sensitivity (<i>p</i> < 0.001), mean GCIPL thickness (<i>p</i> < 0.001), and mean RNFL thickness (<i>p</i> < 0.001) than HC. At 6 and 12 months of observations, GCIPL and RNFL (nasal quadrant) of MS patients decreased significantly (<i>p</i>=0.007 and <i>p</i>=0.004, respectively). Disease duration and the number of relapses correlated with delayed P100 latency (<i>r</i> = -0.61, <i>p</i> < 0.001 and <i>r</i> = -0.46, <i>p</i>=0.02). GCIPL and RNFL in the SPMS subtype were thinner than in RRMS.</p><p><strong>Conclusions: </strong>The retinal structure and optic nerve function of MS patients are worse than those of normal individuals. GCIPL and RNFL thinning occurs at 6 and 12 months but do not correlate with disease duration, the number of relapses, and degree of disability.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"5573839"},"PeriodicalIF":1.5,"publicationDate":"2021-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225456/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39069242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recurrent Ischemic and Hemorrhagic Stroke in Cameroon: A Case-Control Study.","authors":"Jaurès Kamgang,&nbsp;Francklin Tétinou,&nbsp;Yvan Zolo,&nbsp;Chee Yang Tan,&nbsp;Christian Wambo,&nbsp;Emerancienne J N Fongang,&nbsp;Ulrick Sidney Kanmounye","doi":"10.1155/2021/9948990","DOIUrl":"https://doi.org/10.1155/2021/9948990","url":null,"abstract":"<p><strong>Introduction: </strong>Stroke recurrence accounts for a great percentage of catastrophic complications, yet no comprehensive study has analyzed the factors associated with stroke recurrence in Cameroon. We carried out this case-control study to better understand the factors associated with the stroke recurrence in Cameroon.</p><p><strong>Methods: </strong>We collected sociodemographic, clinical, neuroimaging, laboratory, and therapeutic data of eligible patients who consulted the neurology and cardiology department of the Yaounde Central Hospital in Cameroon. We included all patients at least five years removed from their first stroke event who consulted the authors' institution as of January 15, 2019. Wilcoxon signed-rank and Fisher's exact tests were used. Also, a Cox regression model was used to identify confounders.</p><p><strong>Results: </strong>We recruited 100 patients; seven out of ten patients had hypertension, while six out of 10 had a sedentary lifestyle. Half of the patients consumed alcohol regularly, while one patient out of five had diabetes. Most patients presented with their first stroke event, and a quarter had a stroke recurrence. Stroke recurrence was associated with right handedness (OR = 0.23, 95% CI = 0.16-0.33), congestive heart failure (OR = 3.45, 95% CI = 1.16-10.28), gout (OR = 4.34, 95% CI = 1.09-18.09), dysarthria (OR = 4.34, 95% CI = 1.30-14.54), and facial palsy (OR = 3.96, 95% CII = 1.49 - 10.51), as well as modifiable factors such as elevated abdominal circumference (<i>P</i> < 0.01), systolic blood pressure (<i>P</i> < 0.01), blood glucose level (<i>P</i>I <I 0.01), LDL cholesterol (<i>P</i> < 0.01), and triglyceride levels (<i>P</i> < 0.01). The mulitvariable regression model only identified laterality (<i>B</i> = -1.48, <i>P</i> = 0.04) as a statistically significant explanatory varibale for stroke recurrence.</p><p><strong>Conclusion: </strong>We mapped the landscape of recurrent strokes in Cameroon. There is a need to evaluate the causes of suboptimal drug adherence rates and both the role and adherence to nonpharmacologic interventions.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"9948990"},"PeriodicalIF":1.5,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39081942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis.","authors":"Sandip Kuikel,&nbsp;Robin Rauniyar,&nbsp;Sanjeev Kharel,&nbsp;Anil Bist,&nbsp;Subarna Giri,&nbsp;Sahil Thapaliya,&nbsp;Sunanda Paudel","doi":"10.1155/2021/9961610","DOIUrl":"https://doi.org/10.1155/2021/9961610","url":null,"abstract":"<p><p>Sickle cell anemia (SCA) is an inherited autosomal recessive disease. It is caused due to point mutation that substitutes glutamate with valine at the sixth amino acid position of the beta chain of hemoglobin molecules leading to the sickling of the red blood cells and decreased structural deformability. Silent cerebral infarcts are the most common neurological complication of SCA, while overt stroke comprises substantial burden in patients with SCA. This meta-analysis aimed to find the pooled prevalence of overt stroke in SCA patients and discuss the importance of screening them. PubMed, Embase, and Google Scholar were the electronic databases used to search the studies. A total of 765 articles were retrieved upon detailed searching in the abovementioned databases. After a series of removing duplicate articles, title and abstract screening, and full-text review, 20 articles were found eligible and included in the study. The total number of participants from all the included studies was 3,956, and pooled prevalence of stroke in patients with sickle cell anemia in Asia was found to be 5% (95% CI: 4%, 6%) with a range from 1 to 41%. Stroke occurrence in sickle cell anemia patients is an emergency complication that needs immediate intervention and management. Because of the high prevalence of stroke in patients with sickle cell anemia, clinicians should focus on its prevention and treatment strategies.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"9961610"},"PeriodicalIF":1.5,"publicationDate":"2021-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39250310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Evaluation and Treatment of Patients with Postconcussion Syndrome.","authors":"Vijay Renga","doi":"10.1155/2021/5567695","DOIUrl":"https://doi.org/10.1155/2021/5567695","url":null,"abstract":"<p><p>Postconcussion syndrome (PCS) is a complex set of symptoms occurring in a small percentage of patients following concussion. The condition is characterized by headaches, dizziness, cognitive difficulties, somatosensory issues, and a variety of other symptoms with varying durations. There is a lack of objective markers and standard treatment protocols. With the complexity created by premorbid conditions, psychosomatic issues, secondary gains, and litigations, providers often find themselves in a tough situation in the care of these patients. This article combines literature review and clinical insights with a focus on the underlying pathophysiology of PCS to provide a roadmap for evaluating and treating this condition.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"5567695"},"PeriodicalIF":1.5,"publicationDate":"2021-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181109/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39045737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Screening of Cognitive Impairment in Patients with Multiple Sclerosis: A Cross-Sectional Study in Georgia.","authors":"Nazibrola Botchorishvili,&nbsp;Nino Shiukashvili,&nbsp;Nina Mikeladze,&nbsp;Ann Dzagnidze,&nbsp;Nino Mikava,&nbsp;Maia Tighashvili,&nbsp;Marina Janelidze","doi":"10.1155/2021/5591078","DOIUrl":"https://doi.org/10.1155/2021/5591078","url":null,"abstract":"<p><p>Cognitive impairment (CI) is a common symptom of multiple sclerosis (MS), with a significant negative impact on the occupational and social functioning of patients. This study aimed to estimate the prevalence and characteristics of CI among MS patients in Georgia. Sixty-eight patients with MS attending a neurology outpatient clinic in Tbilisi, Georgia, were enrolled in the study. Cognitive status was evaluated using two screening tools: the Brief International Cognitive Assessment for MS and the Montreal Cognitive Assessment. The overall prevalence of CI in our MS patients was 47%. We found negative associations between cognitive test results and patients' age, disability status, and depression. Lower education, higher scores on the Expanded Disability Status Scale, and the progressive course of MS were the main predictors of CI in the logistic regression analysis. This is the first study in Georgia to evaluate CI in patients with MS. The prevalence of CI in our study was comparable with those reported in other countries; however, we found greater impairment of the executive system compared to other cognitive domains. In our study, patients who were on continuous DMT showed significantly better performance on the cognitive tests used, indicating possible favorable effect of immunomodulatory drugs on cognition.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"5591078"},"PeriodicalIF":1.5,"publicationDate":"2021-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39239109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical and Paraclinical Screening for Celiac Disease in Children with Intractable Epilepsy.","authors":"Golnaz Ghazizadeh Esslami,&nbsp;Bahar Allahverdi,&nbsp;Reza Shervin Badv,&nbsp;Morteza Heidari,&nbsp;Nahid Khosroshahi,&nbsp;Hosein Shabani-Mirzaee,&nbsp;Kambiz Eftekhari","doi":"10.1155/2021/1639745","DOIUrl":"https://doi.org/10.1155/2021/1639745","url":null,"abstract":"<p><strong>Background: </strong>Celiac disease is the inflammatory entropy caused by hypersensitivity to gluten, which occurs in susceptible individuals. Some studies have suggested a link between celiac disease and epilepsy in children. Our aim was to screen for clinical and paraclinical features of celiac disease in children with intractable epilepsy.</p><p><strong>Methods: </strong>This was a cross-sectional study. Children aged 2 to 18 years with refractory epilepsy that referred to the pediatric neurology clinic within one year (2018-2019) were enrolled. Demographic and clinical characteristics of patients, especially clinical manifestations of celiac disease, were recorded in a questionnaire. A venous blood sample was sent to determine the total IgA, anti-tTG (IgA), and anti-endomysial antibody (IgA). Endoscopy was performed in cases where the celiac serological test was positive.</p><p><strong>Results: </strong>Seventy children with idiopathic drug-resistant epilepsy (44 boys) were evaluated. The height-for-age index was 49.2% and the weight-for-age index was 38.2% less than normal. Constipation (48.6%), anorexia (25.7%), and abdominal pain (21.4%) were the most common gastrointestinal symptoms. Celiac serological tests were negative in all children. Therefore, endoscopy and bowel biopsy were not performed in any case.</p><p><strong>Conclusion: </strong>Celiac disease was not found in any patient with intractable epilepsy. Gastrointestinal symptoms and growth disorders in this group may be related to the underlying disease or medications and not to celiac disease.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"1639745"},"PeriodicalIF":1.5,"publicationDate":"2021-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38964224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypnotic Effect of <i>A</i>. <i>absinthium</i> Hydroalcoholic Extract in Pentobarbital-Treated Mice.","authors":"Hassan Rakhshandeh, Amirhossein Heidari, Ali Mohammad Pourbagher-Shahri, Roghayeh Rashidi, Fatemeh Forouzanfar","doi":"10.1155/2021/5521019","DOIUrl":"10.1155/2021/5521019","url":null,"abstract":"<p><strong>Background: </strong>Current drugs used in the management of insomnia are associated with side effects. The use of medicinal herbs for insomnia treatment has recently been suggested.</p><p><strong>Objective: </strong>The present study aimed to determine the hypnotic activity of the hydroalcoholic extract of <i>Artemisia absinthium (A</i>. <i>absinthium)</i> in mice.</p><p><strong>Method: </strong>The toxicity of <i>A</i>. <i>absinthium</i> extract is assessed by their lethal dose 50% (LD50), and cytotoxicity evaluation was also done with PC12 cell lines by MTT assay. <i>A</i>. <i>absinthium</i> extract (25, 50, 100, and 200 mg/kg) and 3 fractions (<i>n</i>-butanol fraction (NBF), ethyl acetate fraction (EAF), and aqueous fraction (AQF)) were administered intraperitoneally30 minutes before 30 mg/kg pentobarbital intraperitoneal injection; after that, the sleeping time and sleep latency were recorded.</p><p><strong>Results: </strong>The LD50 value was 2.4 g/kg. The extracts tested showed no negative effect on the proliferation of PC12 cells. <i>A</i>. <i>absinthium</i> extract increased the duration of pentobarbital-induced sleep at doses of 100 and 200 mg/kg (<i>P</i> < 0.01-<i>P</i> < 0.001). Similarly, AQF, EAF, and NBF at 200 mg/kg could increase sleep duration (<i>P</i> < 0.05). The sleep latency was decreased by <i>A</i>. <i>absinthium</i> extract at doses of 100 and 200 mg/kg (<i>P</i> < 0.05-<i>P</i> < 0.01), AQF (<i>P</i> < 0.05), and EAF (<i>P</i> < 0.05). Besides, flumazenil reversed the hypnotic effect of <i>A</i>. <i>absinthium</i> extract (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong><i>A</i>. <i>absinthium</i> extract probably demonstrated sleep-enhancing effects by regulating GABAergic system.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"5521019"},"PeriodicalIF":1.5,"publicationDate":"2021-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084640/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38964225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prediction Score for Cervical Spine Fracture in Patients with Traumatic Neck Injury.","authors":"Natsinee Athinartrattanapong,&nbsp;Chaiyaporn Yuksen,&nbsp;Sittichok Leela-Amornsin,&nbsp;Chetsadakon Jenpanitpong,&nbsp;Sirote Wongwaisayawan,&nbsp;Pittavat Leelapattana","doi":"10.1155/2021/6658679","DOIUrl":"https://doi.org/10.1155/2021/6658679","url":null,"abstract":"<p><strong>Background: </strong>Cervical spine fracture is approximately 2%-5%. Diagnostic imaging in developing countries has several limitations. A computed tomography scan is not available 24 hours and not cost-effective. This study aims to develop a clinical tool to identify patients who must undergo a computed tomography scan to evaluate cervical spine fracture in a noncomputed tomography scan available hospital.</p><p><strong>Methods: </strong>The study was a diagnostic prediction rule. A retrospective cross-sectional study was conducted between August 1, 2016, and December 31, 2018, at the emergency department. This study included all patients aged over 16 years who had suspected cervical spine injury and underwent a computed tomography scan at the emergency department. The predictive model and prediction scores were developed via multivariable logistic regression analysis.</p><p><strong>Results: </strong>375 patients met the criteria. 29 (7.73%) presented with cervical spine fracture on computed tomography scan and 346 did not. Five independent factors (i.e., high-risk mechanism of injury, paraparesis, paresthesia, limited range of motion of the neck, and associated chest or facial injury) were considered good predictors of C-spine fracture. The clinical prediction score for C-spine fracture was developed by dividing the patients into three probability groups (low, 0; moderate, 1-5; and high, 6-11), and the accuracy was 82.52%. In patients with a score of 1-5, the positive likelihood ratio for C-spine fracture was 1.46. Meanwhile, those with a score of 6-11 had an LR+ of 7.16.</p><p><strong>Conclusion: </strong>In a noncomputed tomography scan available hospital, traumatic spine injuries patients with a clinical prediction score ≥1 were associated with cervical spine fracture and should undergo computed tomography scan to evaluate C-spine fracture.</p>","PeriodicalId":19124,"journal":{"name":"Neurology Research International","volume":"2021 ","pages":"6658679"},"PeriodicalIF":1.5,"publicationDate":"2021-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25558800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}